QART Medical

3D Imaging System of Individual Sperm Cells

Health Tech & Life Sciences
Active
Series A Ra'anana, Israel Founded 2018
Last updated 2026-06-18
Total raised
Last: 2024-03
Stage
Series A
Founded
2018
Headcount
8
HQ
Ra'anana, Israel
Sector
Health Tech & Life Sciences

About

Quantitative Assisted Reproductive Technologies (QART) Medical is a clinical-stage company developing a solution for highly informative characterization and selection of sperm cells for in vitro fertilization (IVF). The QART system aims to improve on the current success rates of intracytoplasmic sperm injection (ICSI) by quantitatively characterizing the morphology and contents of individual sperm cells with stain-free, real-time 3D topographic imaging, providing quantitative DNA integrity information on a cell-by-cell basis and automatically sorting a semen sample according to objective consensus criteria. The QART system is a compact, stand-alone benchtop clinical workstation. It is based upon a built-in quantitative phase interferometric microscopy (IPM) imaging microscopy platform and has a microfluidics sorting stage, all controlled via a simple personal computer. Per ICSI cycle, a disposable cartridge containing the semen specimen is inserted into the workstation.

Funding history · 4 rounds · — total

Q&A

What is QART Medical's primary focus?
QART Medical is a clinical-stage company developing a solution for the characterization and selection of sperm cells for in vitro fertilization (IVF), aiming to improve the success rates of intracytoplasmic sperm injection (ICSI).
When was QART Medical founded?
QART Medical was founded in April 2018.
How many employees does QART Medical have?
QART Medical has 1-10 employees.
Which investors participated in QART Medical's September 2020 funding round?
The September 2020 funding round included The Chartered Group.
Has QART Medical received any grants?
Yes, QART Medical received a grant from the Israel Innovation Authority in December 2020.
Who are the co-founders of QART Medical?
The co-founders of QART Medical are Alon Shalev (CEO) and Prof. Natan (Chief Scientific Officer).
What technology does QART Medical's system utilize?
The QART system is based on a built-in quantitative phase interferometric microscopy (IPM) imaging platform and includes a microfluidics sorting stage.
In which sector does QART Medical primarily operate?
QART Medical primarily operates in the Health Tech & Life Sciences sector.

Team · 3

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-Founder, Chief Scientific Officer
LinkedIn ↗
Founder · Co-founder & CSO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Simulation & Imaging
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

bioconvergencefemtechmedical-technologiesclinicspregnancyfertilityhospitalswomen-healthdiagnosticswomenreal-timedigital-healthcare3d-imagingdoctorsmonitoringdecision-support
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)